Cytosorbents president & COO Vincent Capponi buys $12,536 in stock

Cytosorbents Corp President and COO Vincent Capponi made a stock purchase of 2,073 shares on September 14, 2026, valuing the acquisition at $12,536. This brought Capponi's direct beneficial ownership to 40,387 shares, following a 67% drop in the stock's price over the past year. The company's market cap stands at $18 million. Capponi's purchase also includes various RSUs that will convert to common stock.

The financial performance of Cytosorbents improved in Q2 2026 with a modest revenue increase and better gross margins, despite flat revenue year-over-year.